Diamond Hill Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.15M | Hold |
34,277
| – | – | 0.02% | 146 |
|
2025
Q1 | $3.82M | Buy |
34,277
+3,562
| +12% | +$397K | 0.02% | 138 |
|
2024
Q4 | $2.99M | Buy |
30,715
+3,715
| +14% | +$362K | 0.01% | 153 |
|
2024
Q3 | $3.11M | Hold |
27,000
| – | – | 0.01% | 147 |
|
2024
Q2 | $2.87M | Buy |
27,000
+3,466
| +15% | +$369K | 0.01% | 144 |
|
2024
Q1 | $2.28M | Buy |
23,534
+2,560
| +12% | +$248K | 0.01% | 144 |
|
2023
Q4 | $2.12M | Buy |
20,974
+845
| +4% | +$85.3K | 0.01% | 145 |
|
2023
Q3 | $2.05M | Buy |
20,129
+1,600
| +9% | +$163K | 0.01% | 143 |
|
2023
Q2 | $1.87M | Sell |
18,529
-1,420
| -7% | -$143K | 0.01% | 146 |
|
2023
Q1 | $1.84M | Sell |
19,949
-1,527
| -7% | -$140K | 0.01% | 145 |
|
2022
Q4 | $1.95M | Hold |
21,476
| – | – | 0.01% | 142 |
|
2022
Q3 | $1.63M | Buy |
21,476
+1,497
| +7% | +$114K | 0.01% | 143 |
|
2022
Q2 | $1.69M | Hold |
19,979
| – | – | 0.01% | 143 |
|
2022
Q1 | $1.75M | Hold |
19,979
| – | – | 0.01% | 140 |
|
2021
Q4 | $1.75M | Buy |
19,979
+6,078
| +44% | +$532K | 0.01% | 139 |
|
2021
Q3 | $1.14M | Buy |
13,901
+5,210
| +60% | +$426K | ﹤0.01% | 139 |
|
2021
Q2 | $793K | Buy |
8,691
+1,135
| +15% | +$104K | ﹤0.01% | 138 |
|
2021
Q1 | $646K | Buy |
7,556
+485
| +7% | +$41.5K | ﹤0.01% | 136 |
|
2020
Q4 | $668K | Buy |
7,071
+3,240
| +85% | +$306K | ﹤0.01% | 141 |
|
2020
Q3 | $333K | Buy |
3,831
+390
| +11% | +$33.9K | ﹤0.01% | 143 |
|
2020
Q2 | $301K | Hold |
3,441
| – | – | ﹤0.01% | 146 |
|
2020
Q1 | $284K | Buy |
3,441
+440
| +15% | +$36.3K | ﹤0.01% | 141 |
|
2019
Q4 | $284K | Buy |
3,001
+480
| +19% | +$45.4K | ﹤0.01% | 149 |
|
2019
Q3 | $219K | Buy |
+2,521
| New | +$219K | ﹤0.01% | 159 |
|